Published price vs quote-only
Wellorithm vs Novi: Which One Publishes Its Price? (2026)
Wellorithm or Novi? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.5 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
The choice between Wellorithm and Novi usually comes down to one difference that neither homepage puts in its headline.
One of these programs can be evaluated before you start it and one cannot. Novi lists Semaglutide from $133/mo, tirzepatide from $166/mo; with Wellorithm, pricing is not published; you receive a quote only after completing the intake quiz.
The comparison below starts from published pricing, converts it into annual cost, and then asks what the more expensive side is delivering for the difference. Anything a provider declines to disclose is marked undisclosed rather than filled in.
The short answer
- Easier to price in advance
- Novi — Semaglutide from $133/mo, tirzepatide from $166/mo. The other side quotes after intake, so a like-for-like total is not available before you apply.
- Most support for the money
- Novi — No long-term contract, cancel anytime.
- Tirzepatide access
- Novi — Tirzepatide at $166/mo; the other side publishes semaglutide only.
- Easiest to pay for
- Wellorithm — Neither publishes financing; both expect the full amount monthly.
Wellorithm and Novi, side by side
The rows below are the ones that differ enough between these two to be worth your attention.
| Wellorithm | Novi | |
|---|---|---|
| Advertised price | Priced after the eligibility quiz | Semaglutide from $133/mo, tirzepatide from $166/mo |
| Rate after promotions | not published before intake | $133/mo |
| Pricing structure | Quoted only after intake | Published rate per medication |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide and compounded tirzepatide |
| Price transparency | Quote only, after intake | Published upfront |
| Membership fee | Not stated | None |
| How fast you start | 2-minute eligibility quiz | Online intake |
| State coverage | All 50 states | Not published |
| Tirzepatide | Not published | $166/mo |
| Patient reviews | 3,240 | 50,124 |
| eRxDoctor score | 7.5/10 | 7.0/10 |
The real cost: six months and twelve
Comparing entry prices across these two would be actively misleading, because they escalate differently. The totals below are the honest version, built from the rates each provider publishes.
| Wellorithm | Novi | |
|---|---|---|
| First month | Not published | $133 |
| Months 2 onward | Not published | $133/mo |
| 6-month total | Not computable | $798 |
| 12-month total | Not computable | $1,596 |
| Best published plan | No multi-month discount published | No multi-month discount published |
A like-for-like annual total is not available for Wellorithm: pricing is not published; you receive a quote only after completing the intake quiz. Treat any comparison that quotes one as an estimate someone else has made for you.
Pricing you can check, and pricing you cannot
With Novi the arithmetic is available in advance — Semaglutide from $133/mo, tirzepatide from $166/mo, on published rate per medication terms — so it can be compared against anything else on the market.
Wellorithm withholds the figure until 2-minute eligibility quiz is complete — pricing is not published; you receive a quote only after completing the intake quiz. Whatever the reason, it moves the price conversation to after your commitment rather than before it.
Treat Wellorithm's quote as the start of the comparison rather than the end of it, and check specifically what happens to the number at higher doses.
Inside the Wellorithm program
Take the 2-Minute Quiz to Check Your Eligibility What it is really selling here is licensed clinicians in all 50 states, which matters in the states where GLP-1 telehealth coverage is thin.
Practically: 2-minute eligibility quiz, medication shipped to your home, and a pricing model that is quoted only after intake.
Ongoing care is virtual consultations with licensed clinicians, and the medication list runs to compounded semaglutide and compounded tirzepatide.
Wellorithm pros
- Strong fit for patients in states with limited GLP-1 telehealth access
- Licensed clinicians in all 50 states, broader coverage than many smaller platforms
- Both compounded semaglutide and tirzepatide available
- Fully virtual consultations with medication shipped to your home
Wellorithm cons
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- Pricing is not published, you only get a quote after completing the intake quiz
- Smaller, less-established platform with limited public reviews
Where it gives ground to Novi: a smaller platform with no published price and limited public review volume.
How Novi works
$200 OFF - GLP-1 for $133 Today In this pairing, its distinguishing feature is the narrowest gap here between semaglutide and tirzepatide pricing, at $133 and $166.
From signup to first shipment: online intake, then free 2-day shipping with every order. Billing follows a published rate per medication structure.
Support: no long-term contract, cancel anytime. The medications on offer are compounded semaglutide and compounded tirzepatide.
Novi pros
- Competitive pricing: semaglutide from $133/month and tirzepatide from $166/month
- Largest patient base on this list, 50,000+ patients, signaling operational maturity
- Both compounded semaglutide and tirzepatide available
- Free 2-day shipping included with every order
Novi cons
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- Tirzepatide ($166) costs more than the semaglutide entry rate
- No published outcome or weight loss guarantee
Set beside Wellorithm, the thing to weigh: the $133 rate depends on a $200-off promotion and there is no outcome guarantee.
Who should choose Wellorithm, and who should choose Novi
Choose Wellorithm if:
- you want to start on their timeline: 2-minute eligibility quiz
- the level of clinical contact suits you: virtual consultations with licensed clinicians
- you would get real value from licensed clinicians in all 50 states, which matters in the states where GLP-1 telehealth coverage is thin
- you are in a state where GLP-1 telehealth coverage is patchy
Choose Novi if:
- you want tirzepatide available without changing provider later
- you would rather use the platform with the longer public record (50,124 reviews)
- you want the full price in front of you before completing an intake
- the feature you would actually use: the narrowest gap here between semaglutide and tirzepatide pricing, at $133 and $166
The compromises on both sides
On price. Only Novi publishes a rate you can plan against (Semaglutide from $133/mo, tirzepatide from $166/mo). The other quotes after intake, which is a cost of a different kind: you cannot budget the year in advance.
On commitment. Neither publishes a multi-month discount, so both are month-to-month decisions and neither asks you to prepay for a response you have not had yet. Neither publishes financing options, so plan for the full amount each month.
On clinical contact. The support models differ — virtual consultations with licensed clinicians against no long-term contract, cancel anytime — and that difference is felt in week two, not week one.
On medication. Wellorithm covers compounded semaglutide and compounded tirzepatide; Novi covers compounded semaglutide and compounded tirzepatide. Only Novi publishes a tirzepatide route, which matters if semaglutide underdelivers.
The clinical evidence, separated from the marketing
Neither Wellorithm nor Novi manufactures the molecule it prescribes, and the clinical evidence behind GLP-1 treatment belongs to the drug rather than to any platform selling access to it.
The NIH position is that weight-management medication works alongside changes in eating and activity, not instead of them, per NIH, NIDDK.
The FDA publishes an ongoing record of semaglutide products marketed for diabetes and weight loss, and which of them it has actually approved, per FDA.
Neither platform's marketing changes any of that. It is the same evidence base whichever one takes your card.
Wellorithm vs Novi: common questions
Which is cheaper to start, Wellorithm or Novi?
Only Novi publishes a first-month figure (Semaglutide from $133/mo, tirzepatide from $166/mo). The other quotes after intake, so a starting-cost comparison is not available in advance.
How much does Wellorithm cost?
Pricing is not published; you receive a quote only after completing the intake quiz. That is the honest answer, and it is the main practical drawback next to Novi, which publishes Semaglutide from $133/mo, tirzepatide from $166/mo upfront. If you go through the intake, ask for the month-two and maintenance-dose prices in writing before paying for the first month.
Which has more patient reviews, Wellorithm or Novi?
Novi, with 50,124 against 3,240. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
How fast can I start with Wellorithm compared with Novi?
Wellorithm advertises 2-minute eligibility quiz, with medication shipped to your home. Novi advertises online intake, with free 2-day shipping with every order. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Do Wellorithm or Novi take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
What happens if I stop taking the medication?
Both programs are month to month, which makes stopping easy and makes the consequence of stopping the thing to plan for: published extension data shows most of the lost weight returns within about a year. That is an argument for choosing on annual cost rather than entry price.
The verdict
Neither of these two publishes enough for a clean cost verdict, which is itself the finding. Wellorithm leads on licensed clinicians in all 50 states, which matters in the states where GLP-1 telehealth coverage is thin; Novi leads on the narrowest gap here between semaglutide and tirzepatide pricing, at $133 and $166.
Before choosing either, get the maintenance-dose price in writing. Without it, any comparison — including this one — is working with half the information.
Whichever way you go, the medication is the same class of drug and the clinical questions belong to a clinician. What you are choosing here is a billing model and a support structure.
Keep comparing
- Wellorithm vs MaximusPublished price vs quote-only
- Wellorithm vs He & She MDPublished price vs quote-only
- Novi vs Elevate HealthSame price, different service model
- Novi vs TMatesTirzepatide access
- TrimRx vs WellorithmPublished price vs quote-only
- TrimRx vs DirectmedsPublished price vs quote-only
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Wellorithm or Novi, and does not sell treatment. Read our ranking methodology.